Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
•
Neuro-infectious disease
When do you consider pembrolizumab for the treatment of progressive multifocal leukoencephalopathy?
Related Questions
What is your disease modifying treatment of choice for a patient with relapsing remitting multiple sclerosis with treated, well controlled HIV?
What is your approach to immune management in opsoclonus-myoclonus-ataxia syndrome?
Would you consider anti-CD20 agents for treatment of multiple sclerosis in patients with history of breast cancer?
What is your workup and treatment approach for cranial neuropathies in patients with lupus?
Can you use a JAK inhibitor and Mavenclad in a patient with both multiple sclerosis and rheumatoid arthritis?
Do you choose an antibiotic with CSF penetration, such as nafcillin over cefazolin, in the setting of MSSA endocarditis with septic emboli to the brain (assuming no concomitant meningitis or brain abscess)?
What therapy do you recommend in situations where IV steroids and IVIg do not help patients with GABA-A encephalitis?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
What is your approach to dosing rituximab in patients with multiple sclerosis?
What baseline visual testing, if any, do you recommend at diagnosis for patients with multiple sclerosis who deny visual complaints?
